United States · FDA National Drug Code directory

Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0172-2089_6659686c-94ec-408c-b0bb-c78528aaa6c0
Product NDC
0172-2089
Form
TABLET
Composition / generic term
Hydrochlorothiazide
Labeler
Teva Pharmaceuticals USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
19800107
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (0172-2089-60) · 0172-2089-60
  • 1000 TABLET in 1 BOTTLE (0172-2089-80) · 0172-2089-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →